MA46641A - Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteur - Google Patents
Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteurInfo
- Publication number
- MA46641A MA46641A MA046641A MA46641A MA46641A MA 46641 A MA46641 A MA 46641A MA 046641 A MA046641 A MA 046641A MA 46641 A MA46641 A MA 46641A MA 46641 A MA46641 A MA 46641A
- Authority
- MA
- Morocco
- Prior art keywords
- vector
- compositions
- preventing
- transmission
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662415287P | 2016-10-31 | 2016-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA46641A true MA46641A (fr) | 2019-09-04 |
Family
ID=62025507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA046641A MA46641A (fr) | 2016-10-31 | 2017-10-30 | Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteur |
Country Status (10)
Country | Link |
---|---|
US (1) | US20200061026A1 (fr) |
EP (1) | EP3532041A4 (fr) |
JP (1) | JP2020503369A (fr) |
KR (1) | KR20190091268A (fr) |
CN (1) | CN110167540A (fr) |
AU (1) | AU2017347886A1 (fr) |
CA (1) | CA3042306A1 (fr) |
MA (1) | MA46641A (fr) |
MX (1) | MX2019005040A (fr) |
WO (1) | WO2018081733A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112020011506A2 (pt) * | 2017-12-12 | 2020-11-17 | Intervet International B.V. | composições farmacêuticas de isoxazolina implantáveis e usos das mesmas |
IL307992A (en) | 2017-12-15 | 2023-12-01 | Tarsus Pharmaceuticals Inc | Parasitic formulations containing isoxazoline and methods for treating blepharitis |
KR20220054241A (ko) * | 2019-04-04 | 2022-05-02 | 타르서스 파마수티칼스, 아이엔씨. | 벡터 매개 및 바이러스성 질환의 치료 또는 예방을 위한 전신 이속사졸린 구충제 |
CN113345595B (zh) * | 2021-05-17 | 2023-06-09 | 上海大学 | 时序网络上基于检测和接触追踪的流行病干预方法 |
CN115671040B (zh) * | 2021-07-21 | 2024-02-27 | 瑞普(天津)生物药业有限公司 | 一种控制动物寄生虫感染的外用制剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5439924A (en) * | 1991-12-23 | 1995-08-08 | Virbac, Inc. | Systemic control of parasites |
TWI430995B (zh) * | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
US9820977B2 (en) * | 2008-10-03 | 2017-11-21 | Bayer Healthcare Llc | Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
WO2012155352A1 (fr) * | 2011-05-19 | 2012-11-22 | Eli Lilly And Company | Composés de dihydroisoxazole, utilisations antiparasitaires et préparations associées |
AU2013245008B2 (en) * | 2012-04-04 | 2017-03-30 | Intervet International B.V. | Soft chewable pharmaceutical products |
US10456358B2 (en) * | 2013-12-20 | 2019-10-29 | Intervet Inc. | Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals |
KR20160104065A (ko) * | 2014-01-03 | 2016-09-02 | 바이엘 애니멀 헬스 게엠베하 | 농약으로서의 신규 피라졸릴헤테로아릴아미드 |
JP6540419B2 (ja) * | 2015-09-24 | 2019-07-10 | 住友化学株式会社 | 有害生物防除用組成物及び有害生物防除方法 |
-
2017
- 2017-10-30 US US16/346,425 patent/US20200061026A1/en not_active Abandoned
- 2017-10-30 JP JP2019544796A patent/JP2020503369A/ja active Pending
- 2017-10-30 WO PCT/US2017/059084 patent/WO2018081733A1/fr unknown
- 2017-10-30 KR KR1020197015635A patent/KR20190091268A/ko not_active Application Discontinuation
- 2017-10-30 AU AU2017347886A patent/AU2017347886A1/en not_active Abandoned
- 2017-10-30 MA MA046641A patent/MA46641A/fr unknown
- 2017-10-30 CA CA3042306A patent/CA3042306A1/fr active Pending
- 2017-10-30 CN CN201780081856.8A patent/CN110167540A/zh active Pending
- 2017-10-30 EP EP17864858.0A patent/EP3532041A4/fr active Pending
- 2017-10-30 MX MX2019005040A patent/MX2019005040A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3532041A1 (fr) | 2019-09-04 |
CA3042306A1 (fr) | 2018-05-03 |
CN110167540A (zh) | 2019-08-23 |
AU2017347886A1 (en) | 2019-06-20 |
EP3532041A4 (fr) | 2020-06-24 |
WO2018081733A1 (fr) | 2018-05-03 |
JP2020503369A (ja) | 2020-01-30 |
US20200061026A1 (en) | 2020-02-27 |
MX2019005040A (es) | 2019-10-30 |
KR20190091268A (ko) | 2019-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA49403A (fr) | Compositions de pde5 et méthodes d'immunothérapie | |
GB201706751D0 (en) | Compositions and methods for treating inflamatory diseases | |
EP3458589A4 (fr) | Compositions et méthodes de traitement de la maladie de huntington | |
IL298690B1 (en) | Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions | |
DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
EP3448874A4 (fr) | Compositions pour le traitement de maladies | |
EP3448875A4 (fr) | Compositions pour le traitement de maladies | |
EP3448987A4 (fr) | Compositions pour le traitement de maladies | |
MA43515A (fr) | Méthodes et compositions d'inhibition de l'interaction de la ménine avec les protéines mll | |
EP3359662A4 (fr) | Compositions et méthodes pour traiter la maladie de huntington et les troubles apparentés | |
EP3139966A4 (fr) | Méthodes et compositions de traitement de la maladie de huntington | |
SG11202001725SA (en) | Synthetic cannabidiol compositions and methods of making the same | |
MA46641A (fr) | Méthodes et compositions permettant d'empêcher la transmission de maladies propagées par un vecteur | |
MA45688A (fr) | Compositions et procédés de potentialisation d'agents antimicrobiens | |
EP3402533A4 (fr) | Méthodes et compositions pour le traitement d'une maladie neurologique | |
IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
EP3182989A4 (fr) | Méthodes et compositions destinées à prévenir et à traiter une maladie | |
EP3592345A4 (fr) | Compositions et méthodes pour le traitement de maladies inflammatoires | |
EP3429598A4 (fr) | Compositions et méthodes de traitement de maladies et de troubles associés à la bêta-caténine | |
MA42690A (fr) | Micropropagation d'un dattier abada | |
IL257259A (en) | Motile sperm domain containing protein 2 and inflammation | |
DK3562921T3 (da) | Smøremiddelsammensætning indbefattende n-alkyleret dianilin | |
EP3443105A4 (fr) | Plantes de cannabis améliorées et procédés pour les produire et l'utiliser | |
EP3509614A4 (fr) | Méthodes et compositions pour le traitement de la maladie de lafora | |
EP3430017A4 (fr) | Compositions et méthodes pour traiter les parasitoses |